Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Operating Expenses | 41 | 62 | 59 | 65 | 200 |
| Operating Income | -41 | -62 | -59 | -65 | -200 |
| Other Income | 5 | 6 | 10 | 13 | 28 |
| Pre-tax Income | -36 | -56 | -48 | -53 | -172 |
| Net Income Continuous | -36 | -56 | -48 | -53 | -172 |
| Net Income | $-36 | $-56 | $-48 | $-53 | $-172 |
| EPS Basic Total Ops | -1.00 | -2.00 | -2.00 | -2.00 | -4.00 |
| EPS Basic Continuous Ops | -1.23 | -2.49 | -1.66 | -1.67 | -4.38 |
| EPS Diluted Total Ops | -1.00 | -2.00 | -2.00 | -2.00 | -4.00 |
| EPS Diluted Continuous Ops | -1.23 | -2.49 | -1.66 | -1.67 | -4.38 |
| EBITDA(a) | $-41 | $-62 | $-59 | $-65 | $-200 |